We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+29.7%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.09B
AUM Growth
+$568M
Cap. Flow
+$422M
Cap. Flow %
38.69%
Top 10 Hldgs %
23.6%
Holding
197
New
132
Increased
39
Reduced
16
Closed
6

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$26.1M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
+$20M
3
ARVN icon
Arvinas
ARVN
+$19.8M
4
BPMC
Blueprint Medicines
BPMC
+$19.7M
5
CSII
Cardiovascular Systems, Inc.
CSII
+$18.2M

Top Sells

Rank Stock Value
1
APRE icon
Aprea Therapeutics
APRE
+$18.2M
2
KYNB
Kyntra Bio
KYNB
+$12M
3
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$10.7M
4
TDOC icon
Teladoc Health
TDOC
+$10.1M
5
BIIB icon
Biogen
BIIB
+$8.9M

Sector Composition

Rank Sector Weight
1 Healthcare 86.26%
2 Industrials 4.93%
3 Technology 1.47%
4 Energy 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRSP icon
51
CRISPR Therapeutics
CRSP
$4.73B
$8.41M 0.77%
114,400
+103,650
+964% +$6.06M
MASI
52
DELISTED
Masimo
MASI
$8.4M 0.77%
+36,858
New +$8.09M
MTEM
53
DELISTED
Molecular Templates, Inc.
MTEM
$8.21M 0.75%
39,678
+15,372
+63% +$3.57M
MRK icon
54
Merck
MRK
$322B
$7.51M 0.69%
101,813
-5,502
-5% -$414K
AZN icon
55
AstraZeneca
AZN
$263B
$7.5M 0.69%
70,900
-12,000
-14% -$1.24M
PFE icon
56
Pfizer
PFE
$143B
$7.22M 0.66%
232,829
+195,939
+531% +$6.66M
MRNA icon
57
Moderna
MRNA
$21.8B
$7.21M 0.66%
112,256
+90,256
+410% +$4.94M
GILD icon
58
Gilead Sciences
GILD
$162B
$7.09M 0.65%
92,150
+28,500
+45% +$2.18M
AMGN icon
59
Amgen
AMGN
$208B
$7.07M 0.65%
29,953
+15,550
+108% +$3.55M
ZNTL icon
60
Zentalis Pharmaceuticals
ZNTL
$337M
$6.92M 0.64%
+144,200
New +$5.53M
ABT icon
61
Abbott
ABT
$183B
$6.74M 0.62%
73,698
– –
PODD icon
62
Insulet
PODD
$11.5B
$6.36M 0.58%
+32,738
New +$6.26M
GH icon
63
Guardant Health
GH
$21.5B
$6.13M 0.56%
75,552
+66,302
+717% +$5.34M
CI icon
64
Cigna
CI
$73.8B
$5.42M 0.5%
28,907
-10,100
-26% -$1.92M
CSTL icon
65
Castle Biosciences
CSTL
$849M
$5.41M 0.5%
+143,500
New +$4.9M
LLY icon
66
Eli Lilly
LLY
$1.02T
$5.06M 0.46%
30,815
-4,500
-13% -$691K
IDXX icon
67
Idexx Laboratories
IDXX
$44.1B
$4.26M 0.39%
+12,900
New +$3.74M
VRTX icon
68
Vertex Pharmaceuticals
VRTX
$121B
$4.26M 0.39%
14,671
-1,500
-9% -$407K
MDT icon
69
Medtronic
MDT
$109B
$3.83M 0.35%
41,751
– –
ALGN icon
70
Align Technology
ALGN
$12.1B
$3.29M 0.3%
+12,000
New +$2.7M
AMED
71
DELISTED
Amedisys
AMED
$3.14M 0.29%
+15,825
New +$2.95M
ALNY icon
72
Alnylam Pharmaceuticals
ALNY
$27.5B
$2.61M 0.24%
17,600
-60,200
-77% -$8.12M
WST icon
73
West Pharmaceutical
WST
$24B
$2.57M 0.24%
+11,300
New +$2.22M
LH icon
74
Labcorp
LH
$25.4B
$2.48M 0.23%
+17,344
New +$2.4M
CAH icon
75
Cardinal Health
CAH
$53.9B
$2.38M 0.22%
+45,500
New +$2.35M
1 2
3
4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Sectoral Asset Management held 197 positions worth $1.09B, up 109% from $521M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Sectoral Asset Management deployed $422M of net new capital in Q2 2020, opening 132 new positions and adding to 39 existing holdings. Its largest new stake was Centene: 401,158 shares worth $25.5M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 86% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Aprea Therapeutics, an estimated $18.2M trimmed.

  • Sectoral Asset Management's largest Q2 2020 buy was Centene: 401,158 shares worth $25.5M.
  • Sectoral Asset Management added most to Cardiovascular Systems, Inc. in Q2 2020, an estimated $18.2M increase.
  • Sectoral Asset Management's biggest Q2 2020 reduction was Aprea Therapeutics, cutting an estimated $18.2M.
  • Sectoral Asset Management fully exited Inspire Medical Systems in Q2 2020, selling an estimated $6.81M.
  • Sectoral Asset Management's ten largest holdings make up 24% of its $1.09B portfolio in Q2 2020.
  • Sectoral Asset Management opened 132 new positions and closed 6 in Q2 2020.
  • Sectoral Asset Management's portfolio value rose 109% quarter-over-quarter to $1.09B.

Based on Sectoral Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.